Kaiseraugst, Switzerland

Leo Alig


Average Co-Inventor Count = 3.9

ph-index = 14

Forward Citations = 560(Granted Patents)

Forward Citations (Not Self Cited) = 510(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Liestal, CH (1976 - 1979)
  • Kaiseragust, CH (1980)
  • Magden, CH (2003)
  • Kaiseraugst, CH (1978 - 2006)

Company Filing History:


Years Active: 1976-2006

Loading Chart...
53 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Leo Alig

Introduction

Leo Alig, based in Kaiseraugst, Switzerland, is a prolific inventor with an impressive portfolio of 53 patents. His work primarily centers around pharmaceutical innovations, showcasing his commitment to advancing the field through novel compounds.

Latest Patents

One of Alig's latest patents includes the development of N-(4-carbamimidoyl-phenyl)-glycine derivatives. This invention focuses on unique compounds expressed by a specific formula, which includes various variations and physiologically usable salts of these compounds. His advancements in this area have the potential to contribute significantly to therapeutic applications.

Career Highlights

Leo Alig has had a distinguished career, including his tenure at Hoffmann-La Roche Inc., a leading global pharmaceutical company. During his time there, he has made notable contributions to the field of pharmaceuticals through his inventive efforts.

Collaborations

Throughout his career, Alig has collaborated with key professionals in the industry, including Marcel Muller and Thomas Weller. These partnerships have undoubtedly played a role in enhancing the quality and reach of his innovative work.

Conclusion

With a total of 53 patents, Leo Alig exemplifies the spirit of innovation within the pharmaceutical industry. His latest inventions, particularly in N-(4-carbamimidoyl-phenyl)-glycine derivatives, highlight his ongoing contributions to science and research. Through collaborations and a strong career foundation, Alig continues to pave the way for future advancements in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…